Prime Medicine PRME Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's common stock, par value (in dollars per share)?
- Prime Medicine (PRME) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Prime Medicine's common stock, par value (in dollars per share) changed year-over-year?
- Prime Medicine's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Prime Medicine's common stock, par value (in dollars per share)?
- Over 4 years (2021 to 2025), Prime Medicine's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.